Overview
Linnea Eriksson practices practicing medicine in Stockholm, Sweden.
Her clinical expertise encompasses Cerebral Hypoxia, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Linnea Eriksson
Is Linnea Eriksson a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Linnea Eriksson is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Linnea Eriksson participate in research or clinical trials?
Yes. Linnea Eriksson has published 14 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Linnea Eriksson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMs. Eriksson isExperienced. Learn about Cerebral Hypoxia.
- Maturity Onset Diabetes of the YoungMs. Eriksson isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Type 2 Diabetes (T2D)Ms. Eriksson isExperienced. Learn about Type 2 Diabetes (T2D).